[1] Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus[J] . N Engl J Med,2013,368(20):1888-1897.
[2] 中华人民共和国国家卫生和计划生育委员会.人感染H7N9禽流感诊疗方案[S] . 第2版.中华人民共和国国家卫生和计划生育委员会,2013.
[3] Kohlmeier JE,Woodland DL. Immunity to respiratory viruses[J] . Annu Rev Immunol,2009,27:61-82.
[4] Kreijtz JH,Fouchier RA,Rimmelzwaan GF. Immune responses to influenza virus infection[J] . Virus Res,2011,162(1-2):19-30.
[5] Kreijtz JH, Bodewes R,van Amerongen G,et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice[J] . Vaccine,2007,25(4):612-620.
[6] Bender BS,Croghan T,Zhang L,et al. Transgenic mice lacking class Ⅰ major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge[J] .J Exp Med,1992,175(4):1143-1145.
[7] Guo H,Santiago F,Lambert K,et al. T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model[J] . J Virol,2011,85(1):448-455.
[8] Hillaire ML,van Trierum SE,Bodewes R,et al. Characterization of the human CD8+ T cell response following infection with 2009 pandemic influenza H1N1 virus[J] . J Virol,2011,85(22):12057-12061.
[9] 纪 霞,张为忠. 呼吸系统感染[M] . 第2 版. 北京:人民出版社,2005:72-73.
[10] Hillaire ML,Vogelzang-van Trierum SE,Kreijtz JH,et al.Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A(H1N1) and swine-origin triple-reassortant H3N2 influenza viruses[J] . J Gen Virol,2013,94(Pt 3):583-592.
[11] 沈 芳,金 鑫,毛会军,等.2009 甲型流行性感冒病毒感染者常规免疫学检测的临床意义[J] .微生物与感染,2009,4 (4):198-202.
[12] Perez-Padilla R,de la Rosa-Zamboni D,Ponce de Leon S,et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico[J] . N Engl J Med,2009,361(7):680-689.
[13] Kaufman SHE,Schell A,Akhmat R. 感染性疾病免疫学[M] . 朱立平,译.北京: 化学工业出版社,2005:334. |